116 related articles for article (PubMed ID: 26698322)
1. Modeling the Time Course of the Tissue Responses to Intramuscular Long-acting Paliperidone Palmitate Nano-/Microcrystals and Polystyrene Microspheres in the Rat.
Darville N; van Heerden M; Erkens T; De Jonghe S; Vynckier A; De Meulder M; Vermeulen A; Sterkens P; Annaert P; Van den Mooter G
Toxicol Pathol; 2016 Feb; 44(2):189-210. PubMed ID: 26698322
[TBL] [Abstract][Full Text] [Related]
2. The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension.
Darville N; van Heerden M; Mariën D; De Meulder M; Rossenu S; Vermeulen A; Vynckier A; De Jonghe S; Sterkens P; Annaert P; Van den Mooter G
J Control Release; 2016 May; 230():95-108. PubMed ID: 27067365
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats.
Darville N; van Heerden M; Vynckier A; De Meulder M; Sterkens P; Annaert P; Van den Mooter G
J Pharm Sci; 2014 Jul; 103(7):2072-2087. PubMed ID: 24845884
[TBL] [Abstract][Full Text] [Related]
4. Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal-cell interactions.
Darville N; Saarinen J; Isomäki A; Khriachtchev L; Cleeren D; Sterkens P; van Heerden M; Annaert P; Peltonen L; Santos HA; Strachan CJ; Van den Mooter G
Eur J Pharm Biopharm; 2015 Oct; 96():338-48. PubMed ID: 26347923
[TBL] [Abstract][Full Text] [Related]
5. Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension.
Procyshyn RM; Lamoure JW; Katzman MA; Skinner PL; Sherman SE
J Pharm Pharm Sci; 2019; 22(1):548-566. PubMed ID: 31730504
[TBL] [Abstract][Full Text] [Related]
6. Rats and rabbits as pharmacokinetic screening tools for long acting intramuscular depots: case study with paliperidone palmitate suspension.
Patel H; Patel P; Modi N; Patel P; Wagh Y; George A; Desai N; Srinivas NR
Xenobiotica; 2019 Apr; 49(4):415-421. PubMed ID: 29642738
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study.
Ravenstijn P; Remmerie B; Savitz A; Samtani MN; Nuamah I; Chang CT; De Meulder M; Hough D; Gopal S
J Clin Pharmacol; 2016 Mar; 56(3):330-9. PubMed ID: 26189570
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia.
Magnusson MO; Samtani MN; Plan EL; Jonsson EN; Rossenu S; Vermeulen A; Russu A
Clin Pharmacokinet; 2017 Apr; 56(4):421-433. PubMed ID: 27743205
[TBL] [Abstract][Full Text] [Related]
9. Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?
Yin J; Collier AC; Barr AM; Honer WG; Procyshyn RM
J Clin Psychopharmacol; 2015 Aug; 35(4):447-9. PubMed ID: 26061612
[TBL] [Abstract][Full Text] [Related]
10. Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS).
Novakovic V; Adel T; Peselow E; Lindenmayer JP
Clin Neuropharmacol; 2013; 36(2):59-62. PubMed ID: 23503549
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Predictors of Continuation of Paliperidone Palmitate Long-Acting Injection Treatment: A 12-Month Naturalistic Cohort Study.
Whale R; Pereira M; Cuthbert S; Fialho R
J Clin Psychopharmacol; 2015 Oct; 35(5):591-5. PubMed ID: 26267419
[TBL] [Abstract][Full Text] [Related]
12. Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable Paliperidone.
Gomeni R; Bressolle-Gomeni F; Fava M
J Clin Pharmacol; 2016 Oct; 56(10):1296-306. PubMed ID: 26899406
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
Tempest M; Sapin C; Beillat M; Robinson P; Treur M
J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
[TBL] [Abstract][Full Text] [Related]
14. Serum Concentrations of Paliperidone After Administration of the Long-Acting Injectable Formulation.
Helland A; Spigset O
Ther Drug Monit; 2017 Dec; 39(6):659-662. PubMed ID: 29040230
[TBL] [Abstract][Full Text] [Related]
15. Model-Informed Drug Development for Long-Acting Injectable Products: Summary of American College of Clinical Pharmacology Symposium.
Sharan S; Fang L; Lukacova V; Chen X; Hooker AC; Karlsson MO
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):220-228. PubMed ID: 33624456
[No Abstract] [Full Text] [Related]
16. Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug.
Nanaki S; Tseklima M; Terzopoulou Z; Nerantzaki M; Giliopoulos DJ; Triantafyllidis K; Kostoglou M; Bikiaris DN
Eur J Pharm Biopharm; 2017 Aug; 117():77-90. PubMed ID: 28389342
[TBL] [Abstract][Full Text] [Related]
17. Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia.
Park EJ; Amatya S; Kim MS; Park JH; Seol E; Lee H; Shin YH; Na DH
Arch Pharm Res; 2013 Jun; 36(6):651-9. PubMed ID: 23543652
[TBL] [Abstract][Full Text] [Related]
18. Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs.
Bettonte S; Berton M; Battegay M; Stader F; Marzolini C
CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):781-794. PubMed ID: 38429889
[TBL] [Abstract][Full Text] [Related]
19. Estimated medical cost reductions for paliperidone palmitate vs placebo in a randomized, double-blind relapse-prevention trial of patients with schizoaffective disorder.
Joshi K; Lin J; Lingohr-Smith M; Fu DJ
J Med Econ; 2015; 18(8):629-36. PubMed ID: 25800457
[TBL] [Abstract][Full Text] [Related]
20. Microcrystals of Ketal-Linked Paliperidone Prodrugs for Long-Acting Antipsychotics.
Xu Z; Liu T; Jiang Y; Chen Z; Shi X; Xu Y; Yu N; Hua X; Liang XJ; Yuan X; Guo S
Mol Pharm; 2022 Nov; 19(11):3846-3857. PubMed ID: 36047719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
